CRSP fundamentals
An in-depth look to CRISPR Therapeutics AG operating, investing, and financing activities
CRSP free cash flow for Q3 24 is -107.13 M USD. For 2023, CRSP free cash flow was -269.85 M USD and operating cash flow was -260.38 M USD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM